𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer

✍ Scribed by Michael L. Cher; Donal Macgrogan; Robert Bookstein; James A. Brown; Robert B. Jenkins; Ronald H. Jensen


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
917 KB
Volume
11
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis


Due to problems with primary tumor cell culture, conventional cytogenetics has yielded little insightful information on chromosomal alterations in prostate cancer. The primary aim of this study was to define the ability of comparative genomic hybridization (CGH) to detect and map genetic deletions in prostate tumors. A secondary aim was to apply multiple assays to individual tumors as a means of deciphering the mechanisms of genetic alterations in prostate cancer. CGH results were compared with allelic imbalance measurements at 29 distinct loci on chromosome 8 in I8 specimens ( I7 malignant and I benign). CGH detected no changes in cases where all informative PCWRFLP loci were retained and detected all p arm deletions consisting of at least two loci. We estimate that in this study, the smallest deletions detected by CGH were approximately 20-30 cM. Physical mapping of subchromosomal arm deletions by CGH correlated well with allelic imbalance mapping by PCWRFLP The data agreed at 88% of loci on 8p and 92% of loci on 8q. Fluorescence in situ hybridization (FISH) with multiple centromere probes and DNA content flow cytometry (FCM) also was performed on selected specimens. FISH revealed two cases of chromosome 8 aneusomy. In these two cases and three others, CGH showed simultaneous p arm deletion and q arm gain, suggesting isochromosome 8q formation. Together, these data suggested that simple chromosomal aberrations were responsible for allelic losses on 8p and allelic gains on 8q in a significant number of prostate tumors. We also used CGH to examine relative DNA sequence copy number throughout the genome. Changes frequently associated with 8p loss include gains of 8q and losses of I3q, 16p, 16q, 17p, 17q, 20q, and Y. Cases with 8p loss exhibited five times the number of alterations as did cases without 8p loss. Genes Chromosom Cancer I /:/53-162 (1994).


πŸ“œ SIMILAR VOLUMES


Cytogenetic profiling using fluorescence
✍ Curtis T. Thompson; Joe W. Gray πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 424 KB

Fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH) allow cytogenetic analyses of primary tumors without culture. CGH allows detection and mapping of allelic imbalance by simultaneous in situ hybridization of differentially labeled tumor (green fluorescing) and norm

Analysis of ovarian borderline tumors us
✍ Nancy G. Wolf; Fadi W. Abdul-Karim; Carol Farver; Evelin SchrΓΆck; Stanislas du M πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 340 KB πŸ‘ 2 views

It is unclear whether ovarian borderline tumors (tumors of low malignant potential) are independent entities or whether they are part of a continuum of tumor progression that culminates in ovarian carcinoma. Little is known about genetic abnormalities in borderline tumors because of the difficulty o

Chromosome arm 20q gains and other genom
✍ W. Michael Korn; Toru Yasutake; Wen-Lin Kuo; Robert S. Warren; Colin Collins; Ma πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 183 KB πŸ‘ 2 views

Comprehensive information about the molecular cytogenetic changes in metastases of colorectal cancer is not yet available. To define such changes in metastases, we measured relative DNA sequence copy numbers by comparative genomic hybridization (CGH). Samples from 27 liver metastases and 6 synchrono

Genetic changes in familial prostate can
✍ Annika RΓΆkman; Pasi A. Koivisto; Mika P. Matikainen; Tuula KuukasjΓ€rvi; Marita P πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 142 KB πŸ‘ 2 views

## Background: Germline mutations in recessive cancer predisposition genes are uncovered by somatic genetic deletions during tumor development. analysis of genetic changes in tumor tissues from patients with an inherited predisposition may therefore highlight regions of the genome containing suscep